Yutaka Tokumaru, MD

Articles by Yutaka Tokumaru, MD

UFT Plus Carboplatin for Head and Neck Cancer

ByMasato Fujii, MD,Yoshihiro Ohno, MD,Yutaka Tokumaru, MD,Yorihisa Imanishi, MD,Minoru Kanke, MD,Toshiki Tomita, MD,Taku Yamashita, MD

Cisplatin plus fluorouracil (5-FU) is widely accepted as neoadjuvant and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma; UFT is also an active agent against this disease. In the first retrospective study, we examined the efficacy of UFT as adjuvant chemotherapy in patients with maxillary cancer.

Latest Updated Articles